Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |